Latest GRAIL News & Updates

See the latest news and media coverage for GRAIL. We track all announcements, press releases, and industry mentions in real time, all in one place.

GRAIL

Biotechnology company focused on early cancer detection

grail.com

Headquarters: Menlo Park, United States
Founded year: 2016
Company type: Private company
Number of employees: 1,100–5,000
Industry: Biotechnology & Medical Research

Last updated September 23

Latest news about GRAIL

In short: GRAIL won FDA panel backing for Galleri and reported 26% revenue growth.

Company announcements

September 23 GRAIL

GRAIL's Galleri test receives favorable advisory vote

The FDA panel voted that benefits outweigh risks for the multi-cancer early detection test. A final regulatory decision is expected in coming months.

September 22 GRAIL

GRAIL publishes Galleri trial results in top journals

Peer-reviewed NEJM and Nature Medicine papers confirm increased early cancer detection with low false positives.

August 7 GRAIL

GRAIL announces FDA advisory committee review of Galleri test

The Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review GRAIL's Premarket Approval application for the Galleri blood test.

August 5 GRAIL

GRAIL reports second quarter 2026 financial results

Total revenue grew 26% to $44.7 million, Galleri volume rose 35% to 61,000, net loss was $110.2 million, and Samsung financing closed.

Media coverage

September 23 GuruFocus

FDA Panel Boosts Optimism for GRAIL Inc (GRAL) Amid Elevated Pri

On September 24, 2026, an FDA advisory panel delivered a largely favorable assessment of GRAIL Inc's...

September 23 MarketScreener

GRAIL, Inc. Reports PATHFINDER 2 Study Findings For Galleri Test In Multi-Cancer Early Detection Blood Testing

GRAIL, Inc. designed and funded the PATHFINDER 2 study. A single blood draw that screens for more than 50 cancers substantially increased cancer detection when...

September 23 NewsBytes

Key advisory committee weighs Grail's Galleri approval and possible reimbursement

An FDA advisory committee will vote today on recommending approval for Grail's Galleri blood test, which claims to detect up to 50 types of cancer.

September 22 BioSpace

FDA Advisory Committee Votes In Favor of Approval of GRAIL’s Galleri® Multi-Cancer Early Detection Test

The FDA convenes advisory committees to obtain independent expert advice. The agency is not bound by the Committee's ...

Never miss news about GRAIL

Track GRAIL and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

GRAIL competitors & trending companies

Browse news for competitors to GRAIL and other trending companies.